Job Description

Ihre Aufgaben



You will develop 2D and organoid models based on human iPSCs to study cardiovascular diseases You will use CRISPR/Cas9 for the targeted genetic modification of iPSCs You will establish suitable high-throughput screening methods for imaging-based analysis You will optimize the workflows for drug screening and automatization You will apply preclinical compound screenings and test AAV-based CRISPR strategies to identify novel therapeutics You will supervise doctoral students and interns

Ihre Qualifikationen



Higher-level university degree (PhD or equivalent) in disciplines or fields related to biology, pharmacology or biochemistry First experience as a Postdoc in the field of translational medicine Planning and execution of complex experimental approaches Hands-on experiences in human iPSC culture, CRISPR/Cas technology, and general molecular biology You can demonstrate your expertise through relevant publications in scientific journals Fluent English in spoken and written, German knowledge is not a prerequisite but an advantage for the position

Wir bieten



Access to state-of-the-art infrastructure for stem cell research, genome editing, advanced imaging, and multi-omics analyses An inspiring, interdisciplinary, and international research environment with strong translational focus Close collaboration with clinical and basic science groups within the University Medical Center Göttingen, Fraunhofer, and national/international consortia, as well as participation in the German Centers for Health Research (DZHK, DZNE, DZKJ). An attractive research location in Göttingen, a vibrant hub of biomedical and cardiovascular research in Germany Support for career development, including mentoring, grant writing, leadership training, and opportunities to present at international conferences A family-friendly workplace with flexible working hours

Einleitungstext



The Stem Cell Unit is dedicated to advancing precision medicine by applying patient-specific induced pluripotent stem cell (iPSC) disease models. We generate and utilize iPSCs for cutting-edge research in genome editing, cardiac differentiation, tissue engineering, and disease modeling. By combining iPSC technology with CRISPR/Cas9 gene editing and state-of-the-art molecular and functional approaches, we investigate the pathophysiology of cardiomyocytes at genomic, omics, functional, and pharmacological levels. Our ultimate goal is to uncover novel mechanisms driving cardiomyopathy and heart failure and to translate these insights into personalized therapeutics and innovative CRISPR-based gene therapies.



We are seeking an experienced and highly motivated postdoctoral fellow who is eager to work at the interdisciplinary interface between basic research and translational medicine. In this role, you will establish advanced iPSC-based cardiac models and apply them in imaging-driven and functional high-throughput screening assays to identify novel therapeutic strategies.